n,n-dimethylarginine has been researched along with Hepatic Failure in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kuik, DJ; Nijveldt, RJ; Rauwerda, JA; Siroen, MP; Teerlink, T; Van Der Hoven, B; van Leeuwen, PA | 1 |
Kuik, DJ; Kuipers, EJ; Meijer, S; Metselaar, HJ; Nijveldt, RJ; Siroen, MP; Teerlink, T; Tilanus, HW; van der Hoven, B; van der Sijp, JR; van Leeuwen, PA; Warlé, MC | 1 |
2 other study(ies) available for n,n-dimethylarginine and Hepatic Failure
Article | Year |
---|---|
Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality.
Topics: Adult; Aged; Analysis of Variance; Arginine; Critical Illness; Cross-Sectional Studies; Enzyme Inhibitors; Female; Humans; Intensive Care Units; Liver Failure; Male; Middle Aged; Multiple Organ Failure; Pilot Projects; Renal Insufficiency; Risk Factors | 2003 |
The transplanted liver graft is capable of clearing asymmetric dimethylarginine.
Topics: Acute Disease; Arginine; Biomarkers; Case-Control Studies; Chronic Disease; Graft Rejection; Humans; Kidney; Liver; Liver Failure; Liver Transplantation; Osmolar Concentration; Postoperative Period; Prospective Studies | 2004 |